1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  
March 2018  
April 2018  
May 2018  
June 2018  
July 2018  
August 2018  
September 2018  
October 2018  
November 2018  
December 2018  
January 2019  
February 2019  
March 2019  
April 2019  
May 2019  
June 2019  
July 2019  
August 2019  
September 2019  
October 2019  
November 2019  
December 2019  
January 2020  
February 2020  
March 2020  
April 2020  
May 2020  
June 2020  
July 2020  
August 2020  
September 2020  
October 2020  
November 2020  
December 2020  
January 2021  
February 2021  
March 2021  
April 2021  
May 2021  
June 2021  
July 2021  
August 2021  
September 2021  
October 2021  
November 2021  
December 2021  
January 2022  
February 2022  
March 2022  
April 2022  
May 2022  
June 2022  
July 2022  
August 2022  
September 2022  
October 2022  
November 2022  
December 2022  
January 2023  
February 2023  
March 2023  
April 2023  
May 2023  
June 2023  
July 2023  
August 2023  
September 2023  
October 2023  
November 2023  
December 2023  
January 2024  
February 2024  
March 2024  

This page is powered by Blogger. Isn't yours?

Monday, June 13, 2016

 

Cure for Alzheimer's closer




































Image Source: ZAZZLE

A treatment to reverse Alzheimer's Disease could be available in five years, it has been revealed.

Experiments on mice have indicated that a new vaccine not only halts the advance of the disease, but repairs damage already done.

It could also be given to patients whose families have a history of Alzheimer's, to prevent them developing the disease.

The research by British, American and Canadian scientists, was being hailed last night as the most significant breakthrough yet. Harry Cayton, chief executive of the Alzheimer's Society, said: 'This really does make us optimistic.'

A growing number of elderly and even middle-aged people are being struck down by the degenerative brain disease, which has some 500,000 sufferers in Britain alone. It causes untold misery to families who are left to care for loved ones who may no longer recognise them.

The vaccine attacks the build-up of a protein called beta-amyloid, which forms a damaging waxy plaque on brain cells. The latest research, reported today in the scienctific journal Nature, suggests the drug not only removes the proteins but can restore mental functions.

Clinical trials of the vaccine, which is
called Betabloc and made by Dublin-based Elan Pharmaceuticals, are already under way in the UK.

Preliminary results appear to show it is safe and has no side-effects. About 80 patients with mild to moderate forms of Alzheimer's are taking part in a second set of safety trials, which are close to completion.

The breakthrough came as researchers worked with mice genetically engineered to develop a disease similar to Alzheimer's.

Scientists already knew that the vaccine could reduce plaques, but they used a new test, devised by experts at Edinburgh University, to evaluate whether it could also improve memory and cognition.

Professor Richard Morris, of Edinburgh's department of neuroscience, said past attempts to find a cure for Alzheimer's had been hampered because there was no way of testing short-term memory in animals given experimental treatments.

He said: 'Patients in the early stage of Alzheimer's disease are often good at remembering events from early in their lives, but keeping track of more recent times is a real problem.

'It is easy enough to distinguish a human's short-term memory, but until now we could not test the same function in rodents.'

The new test involves monitoring the mice in an elaborate 'water maze' where the way out to dry areas is changed frequently.

Researchers in both Toronto and Florida found dramatic improvements in the memories of mice given the drug over several months.

Dr Peter St George-Hyslop of the University of Toronto said: 'Not only were we able to clean up the brain tissue, but we also prevented the behavioural consequences of Alzheimer's.'

The scientists believe their work provides final proof of exactly how Alzheimer's is initiated by chemical changes in the brain, although other factors play a role in its development.

Professor Morris said: 'We know that Alzheimer's sufferers express an abnormal amount of beta-amyloid, which collects in the brain and forms plaques.

'It seems a person's ability to learn and remember things declines as these plaques grow, and we know this is true for both humans and mice.'

The experts stressed that the vaccine could not become generally available until it has been through large-scale clinical trials.

But Mr Cayton, who described the research as 'extremely exciting', said: 'It would not be unrealistic to say that we might see a treat-ment within five years.'

Story Source: The above story is based on materials provided by DAILYMAIL
Note: Materials may be edited for content and length